Mon panier

Recombinant Monoclonal Anti-CD45(LCA) Antibody, Mouse (3G2)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
HGS-S247-20ul
$160.00
HGS-S247-100ul
$470.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Background

    Recombinant Monoclonal Anti-CD45(LCA) Antibody, Mouse (3G2) is a CD45 primary antibody for IHC application. CD45 is an evolutionary highly conserved receptor protein tyrosine phosphatase exclusively expressed on all nucleated cells of the hematopoietic system. It is characterized by the expression of several isoforms, specific to a certain cell type and the developmental or activation status of the cell.

  • Product Specifications

    Host Species
    Mouse
    Isotype
    Mouse IgG
    Clone
    3G2
    Application
    IHC-P
    Dilution Ratio
    1: 200 - 1: 1000
    Form
    Liquid
    Clonality
    Monoclonal
    Reactivity
    Human
    Synonyms
    PTPRC, CD45, GP180, LCA, T200
    Concentration
    0.9~1.1 mg/ml
    Specificity
    React with CD45(LCA) protein on the membrane of target cell/tissue
    Purification Tech
    Protein A
    Preservation
    Tris buffer, 1% BSA
  • Experiment Protocol

    LEICA Experiment Protocol

  • Storage

    Shipped at 4°C, Blue Ice. Store at +4°C for short term (1-2 weeks). Store at -20°C for long term.
    Avoid freeze / thaw cycle. Upon delivery aliquot. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • Sample Staining Data

     CD45 (LCA) SAMPLE STAINING DATA
  •  CD45 (LCA) SAMPLE STAINING DATA
  •  CD45 (LCA) SAMPLE STAINING DATA

    Immunohistochemical analysis of paraffin embedded human cancer tissue labelled with HGS-S247 at 1/500 dilution.
    Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Avis des utilisateurs
Publier un commentaire

Progrès de frontière

 
Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs